Astrana Health (NASDAQ:ASTH) Reaches New 1-Year High – Here’s What Happened

Astrana Health, Inc. (NASDAQ:ASTHGet Free Report) shares reached a new 52-week high during mid-day trading on Monday . The stock traded as high as $40.58 and last traded at $39.6450, with a volume of 67712 shares traded. The stock had previously closed at $39.17.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on ASTH shares. Robert W. Baird set a $45.00 price target on shares of Astrana Health in a research note on Friday, May 8th. Weiss Ratings upgraded shares of Astrana Health from a “hold (c-)” rating to a “hold (c)” rating in a research note on Monday, June 1st. TD Cowen lifted their target price on shares of Astrana Health from $35.00 to $45.00 and gave the stock a “buy” rating in a report on Tuesday, May 12th. Zacks Research upgraded shares of Astrana Health from a “strong sell” rating to a “hold” rating in a research note on Wednesday, March 11th. Finally, Truist Financial increased their price target on shares of Astrana Health from $38.00 to $47.00 and gave the company a “buy” rating in a report on Thursday, May 14th. Seven research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, Astrana Health currently has an average rating of “Moderate Buy” and a consensus price target of $45.00.

View Our Latest Stock Analysis on Astrana Health

Astrana Health Stock Performance

The firm has a market capitalization of $2.30 billion, a PE ratio of 67.54 and a beta of 1.00. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 1.20. The business’s 50 day simple moving average is $36.60 and its two-hundred day simple moving average is $28.35.

Astrana Health (NASDAQ:ASTHGet Free Report) last released its quarterly earnings results on Thursday, May 7th. The company reported $0.74 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.29 by $0.45. Astrana Health had a return on equity of 9.22% and a net margin of 0.86%.The firm had revenue of $965.10 million for the quarter, compared to the consensus estimate of $949.21 million. During the same period last year, the business posted $0.42 EPS. The company’s revenue for the quarter was up 55.6% on a year-over-year basis. Research analysts expect that Astrana Health, Inc. will post 1.25 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the company. Signaturefd LLC increased its position in shares of Astrana Health by 57.9% during the 4th quarter. Signaturefd LLC now owns 1,058 shares of the company’s stock valued at $26,000 after purchasing an additional 388 shares during the last quarter. GAMMA Investing LLC boosted its holdings in shares of Astrana Health by 144.7% in the fourth quarter. GAMMA Investing LLC now owns 1,473 shares of the company’s stock worth $37,000 after buying an additional 871 shares during the last quarter. Strs Ohio purchased a new position in shares of Astrana Health in the fourth quarter worth approximately $40,000. Tower Research Capital LLC TRC grew its position in Astrana Health by 323.3% during the second quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company’s stock valued at $115,000 after buying an additional 3,517 shares during the period. Finally, State of Wyoming bought a new stake in Astrana Health during the second quarter valued at approximately $132,000. 52.77% of the stock is owned by hedge funds and other institutional investors.

About Astrana Health

(Get Free Report)

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.

Read More

Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter.